3 min read
FDA’s Draft Guidance for Data Monitoring Committees (DMCs)
How Veristat’s Proven DMC Expertise for Complex Trials Supports Patient Safety and Sponsor Success
3 min read
How Veristat’s Proven DMC Expertise for Complex Trials Supports Patient Safety and Sponsor Success
4 min read
Each month, Veristat's regulatory team tracks and shares a selection of new Regulatory Guidance updates from the US Food & Drug Administration (FDA) that are pertinent to the governance of clinical trials and drug, biologic, or medical device development...
12 min read
4 min read
Each month, Veristat's regulatory team tracks and shares a selection of new Regulatory Guidance updates from the US Food & Drug Administration (FDA) that are pertinent to the governance of clinical trials and drug, biologic, or medical device development...
3 min read
Clinical trial leaders in small and medium-sized biotech companies regularly find themselves at the intersection of growing requirements, shrinking timelines, and talent shortages. With organizational restructuring and staffing reductions continuing,...
2 min read
Each month, Veristat's regulatory team tracks and shares a selection of new Regulatory Guidance updates from the US Food & Drug Administration (FDA) that are pertinent to the governance of clinical trials and drug, biologic, or medical device development...
1 min read
Learn how Veristat’s multidisciplinary team helped sponsors navigate the complexities of global regulatory submissions, achieving early and successful outcomes.
4 min read
In partnership with Clinical Leader, Veristat consulting, regulatory, and clinical experts gave a live webinar outlining how to better advance new cancer therapies in alignment with FDA’s Project FrontRunner. The webinar covered the following:
5 min read
Each month, Veristat's regulatory team tracks and shares a selection of new Regulatory Guidance updates from the US Food & Drug Administration (FDA) that are pertinent to the governance of clinical trials and drug, biologic, or medical device development...
1 min read
Are you interested in learning about the latest FDA initiative to accelerate the development of new cancer treatments? Veristat's informative webinar "Advancing Development of New Oncology Therapies, aligning with FDA's Project FrontRunner" is an...